Watanabe, H.; Fujishima, F.; Komoto, I.; Imamura, M.; Hijioka, S.; Hara, K.; Yatabe, Y.; Kudo, A.; Masui, T.; Tsuchikawa, T.;
et al. Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors. Cancers 2022, 14, 775.
https://doi.org/10.3390/cancers14030775
AMA Style
Watanabe H, Fujishima F, Komoto I, Imamura M, Hijioka S, Hara K, Yatabe Y, Kudo A, Masui T, Tsuchikawa T,
et al. Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors. Cancers. 2022; 14(3):775.
https://doi.org/10.3390/cancers14030775
Chicago/Turabian Style
Watanabe, Hirofumi, Fumiyoshi Fujishima, Izumi Komoto, Masayuki Imamura, Susumu Hijioka, Kazuo Hara, Yasushi Yatabe, Atsushi Kudo, Toshihiko Masui, Takahiro Tsuchikawa,
and et al. 2022. "Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors" Cancers 14, no. 3: 775.
https://doi.org/10.3390/cancers14030775
APA Style
Watanabe, H., Fujishima, F., Komoto, I., Imamura, M., Hijioka, S., Hara, K., Yatabe, Y., Kudo, A., Masui, T., Tsuchikawa, T., Sakamoto, K., Shiga, H., Nakamura, T., Nakaya, N., Motoi, F., Unno, M., & Sasano, H.
(2022). Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors. Cancers, 14(3), 775.
https://doi.org/10.3390/cancers14030775